Peter Carlson

SITC is deeply concerned by the announcement from NIH that will cut billions of dollars in indirect costs. We urge the NIH & the new administration to reverse this action to ensure life-saving cancer treatments continue to reach the clinic and patients. sitcancer.org/advocacy/indir…

@KimpleRandall @UW_RadoncDHO @UWMadison Congratulations! Very well deserved!!!

Able to officially announce that as of today I have been promoted to Professor in @UW_RadoncDHO @UWMadison. A great many thanks are due... 1/n

Excited to share my work with @ZachMorrisMDPhD and @RPatelMDPHD showing that we can use low-dose systemic molecular targeted radionuclide therapy to enhance immune responses to local solid tumor vaccines!

Please.

New #JITC article: Short-course neoadjuvant in situ vaccination for murine melanoma bit.ly/3IbLhvl

#PubAlert #TeamScience! MSTP students & alums: M4 @PiepsTweeets G4 @JJagodinsky & MSTP alum @PeterCarlsonMD published in @FrontImmunol Radiation Augments the Local Anti-Tumor Effect of In Situ Vaccine With CpG-Oligodeoxynucleotides and Anti-OX40 in I… pubmed.ncbi.nlm.nih.gov/34868010/

Excited to share our new publication which shows that low dose radiopharmaceutical therapy can enhance efficacy of immune checkpoint blockade in “cold” tumors. @ZachMorrisMDPhD @artlab_wisc @JosephGrudzins1 @UPMCHillmanCC @UWCarbone @IOTNmoonshot stm.sciencemag.org/content/13/602…

New #JITC article: Association between body mass index, dosing strategy, and efficacy of immune checkpoint inhibitors @murtaza_ahm jitc.bmj.com/content/9/6/e0…

Four @uwsmph researchers have received prestigious awards from the @ACTScience, including one of @WiscPediatrics very own, Dr. Paul Sondel. More on this award ⬇️: bit.ly/3bz2EbI

Dr. Anna Huttenlocher was recently awarded a two-year grant from @NIH-@niaid for her project, “Imaging Immunometabolism in live animals during host defense.” More on the aims of this study ⬇️: bit.ly/3dFpFeC

Very happy to see our new publication up now on @jitcancer - a simple and effective means of improving variability in implanted mouse tumor models for immunotherapy - depth makes a big difference! Thank you to @RPatelMDPHD @ZachMorrisMDPhD @matrodmed

Congratulations again- so proud of you all!! <3 your MSTP! #MatchDay2021 @uwsmph #doubledocs @PeterCarlsonMD @Cenilicus @AmeliaHaj @JackFVHunt @jrodriguezgil @lcswanson2 @kkrautie

Drs Capitini, DeSantes, Erbe-Gurel, Hank, Huttenlocher, Otto, Rakhmilevich, Sondel and @UWCarbone researchers were recently recognized w/ the @sitcancer Team Science Award for their long-standing contribution to the field of cancer immunotherapy. More: ow.ly/xib150D4OUW

New #JITC article: Identification of neuroblastoma cell lines with uncommon TAZ+/mesenchymal stromal cell phenotype with strong suppressive activity on natural killer cells ow.ly/MZv550D9R8e